Shenglan Li
Baylor College of Medicine(US)Capital Medical University(CN)Huawei Technologies (China)(CN)Beijing Tian Tan Hospital(CN)Brown Foundation(US)The University of Texas Health Science Center(US)Baylor Genetics(US)The University of Texas Health Science Center at Houston(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Pluripotent Stem Cells Research, CRISPR and Genetic Engineering, Ferroptosis and cancer prognosis, RNA modifications and cancer
Most-Cited Works
- → Mining TCGA database for genes of prognostic value in glioblastoma microenvironment(2018)378 cited
- → Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells(2014)233 cited
- → OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome(2019)198 cited
- → Identification of circular RNAs and their targets during tomato fruit ripening(2017)115 cited
- → RNA m6A modification orchestrates a LINE-1–host interaction that facilitates retrotransposition and contributes to long gene vulnerability(2021)99 cited
- → piggyBac mediates efficient in vivo CRISPR library screening for tumorigenesis in mice(2017)91 cited